Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 6 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| C4 Therapeutics Inc | CCCC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 4.38 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.38 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 6 | 6 | - | 1.06 - 11.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 05:35:27 | 1 | $ 4.45 | USD |
C4 Therapeutics (CCCC) Options Flow Summary
C4 Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 300.47M | 68.60M | - | 20.76M | -132.49M | -1.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
C4 Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CCCC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.58 | 5.14 | 4.375 | 4.75 | 1,331,065 | -0.20 | -4.37% |
| 1 Month | 5.72 | 5.86 | 4.375 | 5.03 | 1,177,791 | -1.34 | -23.43% |
| 3 Months | 8.20 | 8.55 | 4.375 | 6.40 | 1,293,204 | -3.82 | -46.59% |
| 6 Months | 4.95 | 11.88 | 4.02 | 6.72 | 3,478,010 | -0.57 | -11.52% |
| 1 Year | 3.35 | 11.88 | 1.06 | 5.12 | 4,741,363 | 1.03 | 30.75% |
| 3 Years | 37.36 | 51.21 | 1.06 | 7.06 | 1,931,013 | -32.98 | -88.28% |
| 5 Years | 26.60 | 51.21 | 1.06 | 8.29 | 1,642,774 | -22.22 | -83.53% |
C4 Therapeutics Description
| C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. |
